Boulevard vs Mangomint (2026): Which One Actually Has Clinical Charting?

You booked the Boulevard demo because your Facebook group swears by it, and the Mangomint demo because a friend two suites over pays half as much and seems just as happy. The Boulevard rep showed a beautiful calendar, a client app, and forms that attach to a chart, then quoted a med-spa number that made you wince. The Mangomint rep showed a cleaner interface, a lower price, and mentioned almost in passing that charting is now included. You are an RN or NP. You inject, you run IVs, some weeks you prescribe. So you hung up with the one question neither rep answered straight: if I put a client’s chart in this thing, will it hold up?

Here is the honest answer up front: as of August 2026 both platforms include forms and charting, so the old “Mangomint has no charting” warning is out of date, and neither one is a clinical EHR. Mangomint is now a single plan at about $120 per location plus $10 per user, with charting and HIPAA support included. Boulevard is a premium booking platform where real charting and HIPAA coverage live in its top med-spa tier at roughly three times the price. If your work is booking, memberships, consents, and treatment notes, both charts are enough and Mangomint wins on cost. If you prescribe, order labs, or need a record that stands up to a board inquiry, you want a clinical EHR. This piece breaks both down across eight things that decide the bill, then runs the math for three real clinic shapes.

Table of contents

1. Why “does it have charting” is the wrong question in 2026
2. The eight things that decide the bill and the risk
3. Pricing and the real monthly cost
4. Charting: what each one actually gives you
5. HIPAA, the BAA, and the compliance trap
6. When neither is enough: the clinical EHR line
7. What a solo IV bar, a prescribing clinic, and a three-location group each pay
8. Where each platform quietly breaks
9. Common objections, answered honestly
10. Frequently asked questions

Why “does it have charting” is the wrong question in 2026

For two years the advice was simple: pick Mangomint for the slick booking, but if you inject or run a clinical service, don’t, because it can’t chart. That advice expired this summer. On August 1, 2026, Mangomint moved every customer onto one simplified plan and made Forms & Charting free for everyone, alongside memberships, express booking, and HIPAA compliance with a signed BAA (Mangomint). The biggest reason a clinical owner used to rule it out is gone.

So the useful question is no longer “does it have charting.” Both do. It is “what kind of record do I actually need, and which platform gives it to me without a surprise bill.” Blur the line between a forms-and-charts tab bolted onto a booking calendar and a clinical EHR built for prescriptions and labs, and you either overpay for depth you never touch or run a prescribing practice on a record never designed to hold one. The stakes are real: the U.S. medical spa market was estimated at roughly $18.6 billion in 2024, with the average single location earning $1,398,833 that year (AmSpa; Grand View Research).

The eight things that decide the bill and the risk

Sources: Mangomint pricing changes, G2 (Boulevard), Capterra (Boulevard). Prices as reported at writing; confirm current figures on each vendor’s page.

Pricing and the real monthly cost

The sticker gap is real, and it is wide. Mangomint’s new model is one of the simplest in the category, and Boulevard’s clinical tier is one of the priciest.

Mangomint retired its old Essentials, Standard, and Unlimited tiers for a single plan: about $120/mo per location plus $10/mo per user, so a solo provider lands near $130/mo (Mangomint). Everything most clinics need day to day, including Forms & Charting, memberships, express booking, and HIPAA support with a BAA, is in that base. Only phone (about $70/mo per line), marketing (from $30/mo), and payroll are separate (Mangomint).

Boulevard prices per location and stacks features up its tiers: about $176/mo for Essentials, $293/mo for Premier, and $410/mo for Prestige billed monthly, with annual billing shaving each down (G2). The one most clinical owners need is the med-spa Aesthetics bundle, about $421/mo billed annually or $468/mo month to month, which layers in HIPAA coverage, charting, and unlimited professionals (Capterra). Where charting is not bundled, it is an add-on around $55 to $65/mo per location, and texts beyond your allowance run a cent or two each.

Illustrative monthly cost by setup, from published 2026 prices before add-ons. Mangomint clinic = one location, four users ($120 + 4 x $10); Boulevard = the med-spa Aesthetics bundle billed annually. Sources: Mangomint, G2.

For a small clinical team, Mangomint is often less than half the monthly cost, and charting is no longer the trade-off it was.

Charting: what each one actually gives you

Both platforms now let you build intake forms, attach consents, drop in photos, and write a treatment note against an appointment. For a lot of clinical work, that is enough. What neither is, is a prescriber’s EHR.

Mangomint’s charting is customizable forms and notes tied to the client record, included for every customer: intake, consent, service notes, photos, and a client history you pull up next visit (Mangomint). Boulevard’s charting is comparable in shape and lives in the Aesthetics bundle.

Here is the line that matters. Neither one orders labs, writes an e-prescription, checks drug interactions, or produces the longitudinal clinical record a medical board expects from a prescribing practice. If your visit ends with “here is your consent and after-care,” a booking-platform chart is fine. If it ends with “I’m sending semaglutide to your pharmacy,” it is not the right home for that record, however nice the forms look. That is a category boundary, not a knock on either product, and ignoring it is how prescribing clinics end up with a chart that cannot carry what they do.

HIPAA, the BAA, and the compliance trap

The most expensive mistake here is not the monthly price. It is turning on client texting and photo storage without the paperwork that makes it legal.

Both platforms offer HIPAA compliance, and both require a signed Business Associate Agreement before any protected health information flows through them. On Mangomint that support is part of the new single plan; on Boulevard it lives in the Aesthetics bundle (Mangomint; G2). Storing a client photo or chart note without a BAA in place is a gap, not a feature the vendor forgot.

Whether HIPAA even applies depends on what you do. If you bill insurance or share protected health information with a lab or a referring physician, you are almost certainly a covered entity and the BAA is non-negotiable (HHS). A pure cash-pay IV bar with no insurance billing may fall outside federal HIPAA, but it still owes state privacy and breach-notification duties, so never assume the exemption.

One more wrinkle is specific to texting. Health-related SMS draws heavier carrier filtering than retail, so 10DLC brand registration matters more here, and the copy has to stay conservative. The FTC has warned almost 700 marketers of health products that unsupported claims could bring civil penalties, and it has sent letters to IV-therapy companies over immune and COVID claims (FTC). Whatever platform sends your reminders, keep “boosts immunity” and “melts fat” out of the automated copy. Our HIPAA-aware SMS guide walks the consent and 10DLC steps in order.

When neither is enough: the clinical EHR line

If you prescribe GLP-1, hormones, or anything controlled, stop comparing booking platforms and go one shelf over.

Boulevard and Mangomint are booking-first products with charting added. They do not e-prescribe, order labs, or produce a prescriber-grade record. For that you want a clinical EHR. Cerbo includes native e-prescribing for standard, controlled, and compounded medications plus deep lab integrations; Healthie adds e-prescribing through a DoseSpot add-on. We compared those two in our Cerbo vs Healthie guide; a prescribing clinic belongs on one of them, not on a spa booking tool.

The GLP-1 point matters because the ground shifted. The FDA declared the semaglutide and tirzepatide shortages resolved in late 2024 and early 2025 and wound down mass compounding, so “shortage” is no longer a valid compounding justification in 2026 (FDA). If weight-loss injectables are your engine, your record-keeping and sourcing both need to be airtight, and that is an EHR-and-pharmacy conversation. For where those lines fall, see our weight-loss automation breakdown.

What a solo IV bar, a prescribing clinic, and a three-location group each pay

One framework, three real shapes. The right answer genuinely changes with each.

Scenario 1: solo cash-pay IV bar, no prescribing

You run drips, sell packages, and never write a prescription, so charting means consents, a quick service note, and the occasional photo. Mangomint at about $130/mo for one location and one seat gives you booking, memberships, and included charting. Boulevard’s Aesthetics bundle at about $421/mo annual buys a more polished client experience, but for a one-chair IV bar that is premium you are unlikely to feel. Unless brand experience is your differentiator, Mangomint is the honest pick.

Scenario 2: RN- or NP-owned clinic that injects and prescribes hormones or GLP-1

Now the comparison changes shape entirely. You need a defensible clinical record, e-prescribing, and lab orders, and neither Boulevard nor Mangomint provides them. The right stack is a clinical EHR such as Cerbo or Healthie, plus a booking layer only if the EHR’s scheduling is weak. Do not make a spa booking tool carry a prescribing practice; the savings are not worth a chart that falls apart under scrutiny. Price the EHR first.

Scenario 3: three-location aesthetics group, injectables plus memberships

Per-location pricing is where this bites. Boulevard’s Aesthetics bundle across three locations runs roughly $1,263/mo billed annually (3 x $421), before texts and add-ons. Mangomint across three locations with twelve users total is about $480/mo (3 x $120 plus 12 x $10), a fraction of that, with charting included at each site. A group that competes on a consistent premium client app may still pay for Boulevard; a group focused on margin will find Mangomint hard to argue with. Our med-spa software cost teardown lays every major vendor side by side.

Where each platform quietly breaks

Every tool has a failure mode the demo will not show you. Here are the ones that actually cost clinics money.

Mangomint breaks when you mistake “charting” for “an EHR.” The new included charting is useful, and that is exactly the trap. A prescribing owner sees “charting included,” signs up to save money, and only later realizes there is no e-prescribing, lab ordering, or prescriber-grade record. It is a category boundary to respect, not a Mangomint flaw. Treat the charting as a booking-side nice-to-have, not your medical record.

Boulevard breaks on cost creep and per-location math. The premium experience is real, but so is the bill. Every location is another full-price line, the clinical features live in the top tier, and add-ons and text overages stack on top (G2). A two- or three-chair clinic can pay enterprise money for polish it does not need. Price the tier that has HIPAA and charting, not the entry number.

Both break at the marketing edge. Neither one reliably chases a no-show back onto the calendar, asks for a review when a client is happiest, or re-warms an IV client who came once and vanished. That gap is the quiet reason so many clinics carry a third subscription. Our post on why IV therapy clients only come once walks the repeat-visit sequence, and that reminder and retention layer can live on a platform you own once.

Common objections, answered honestly

“Mangomint added charting, so isn’t it just the cheaper Boulevard now?” On booking and charting for a non-prescribing clinic, mostly yes, and that is the real 2026 story. Boulevard still earns its premium on client experience, app polish, and multi-location consistency. If that is not your differentiator, the price gap is hard to justify.

“I inject and occasionally prescribe. Can I run everything on one of these?” Not safely. You can book and chart consents in either, but you should not keep your prescribing record in a spa booking tool. Keep the medical record and e-prescribing in a clinical EHR, and use Boulevard or Mangomint only for booking. One tool for everything sounds efficient until an audit.

“I already pay for Boulevard. Is it worth switching to save money?” Count the switching cost honestly. Migrating client records, memberships, and photos is real work, and you want your data-export terms in writing first. A single happy location may not beat the disruption; three locations bleeding on per-location fees, with the clinical record kept elsewhere, tilts the math toward a move.

The bottom line

Back to those two demos. The confusion was never about which calendar is prettier. It was that the old rule of thumb, “Mangomint can’t chart,” stopped being true in August 2026 and nobody updated the advice. For a non-prescribing IV or aesthetics clinic, Mangomint’s included charting and far lower price make it the value pick, while Boulevard earns its premium only if a polished, consistent client experience is your edge. If you prescribe, neither belongs at the center of your stack: put the medical record in a clinical EHR, use a booking tool for booking, and keep marketing and retention on something built for it. To see how much of that follow-up stack can run on a system you buy once, book a quick demo and compare it against the per-seat tools you carry now.

This article is for general informational purposes and is not legal, medical, or compliance advice. Prices are as published or reported at the time of writing and change frequently; confirm the current figure on each vendor’s own page before purchasing. Each practice is responsible for its own HIPAA, TCPA, FTC, DEA, and state-licensing obligations.